Home › Osteosarcoma › California
Osteosarcoma clinical trials in California
18 studies for Osteosarcoma are looking for participants at sites in California.
Cities in California
- Mountain View8 studies
- Los Angeles7 studies
- Oakland4 studies
- San Diego4 studies
- San Francisco4 studies
- Orange3 studies
- Baldwin Park3 studies
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Children's Hospital Los Angeles, Los Angeles
- Lucile Packard Children's Hospital Stanford University, Palo Alto
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- UCSF Benioff Children's Hospital Oakland, Oakland
- Rady Children's Hospital, San Diego
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- University of California San Francisco, San Francisco
RecruitingPhase 1
Ages 5 to 40 · All sexes · Updated Sep 3, 2026 · NCT06156410Losartan + Sunitinib in Treatment of Osteosarcoma
- Children's Hospital Los Angeles, Los Angeles
RecruitingPhase 1
Ages 10 and older · All sexes · Updated Sep 1, 2026 · NCT03900793Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital of Orange County, Orange
- UCSF Medical Center-Mission Bay, San Francisco
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Kaiser Permanente-Anaheim, Anaheim
- PCR Oncology, Arroyo Grande
- Kaiser Permanente-Bellflower, Bellflower
- and 15 more
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165SPEARHEAD-3 Pediatric Study
- Stanford University, Palo Alto
RecruitingPhase 1/2
Ages 2 to 21 · All sexes · Updated Aug 11, 2026 · NCT05642455Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07628634AOH1996 for the Treatment of Refractory Solid Tumors
- City of Hope Medical Center, Duarte
- City of Hope at Long Beach Elm, Long Beach
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT05227326Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- City of Hope Comprehensive Cancer Center, Duarte
- Kaiser Permanente-Oakland, Oakland
- Lucile Packard Children's Hospital Stanford University, Palo Alto
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
RecruitingObservational study
All ages · All sexes · Updated May 11, 2026 · NCT06064682Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
- Stanford University, Palo Alto
RecruitingPhase 1
Ages 2 to 30 · All sexes · Updated May 7, 2026 · NCT06500819Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
- UCLA, Los Angeles
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 1, 2026 · NCT07357519Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- and 5 more
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734Pediatric PET/MR Image Registry
- Stanford University, School of Medicine, Palo Alto
RecruitingObservational study
Up to age 40 · All sexes · Updated Feb 9, 2026 · NCT03458520A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- Kaiser Permanente Oakland Medical Center, Oakland
Recruiting
Ages 13 and older · All sexes · Updated Feb 6, 2026 · NCT06387485Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- UC San Diego Moores Cancer Center, La Jolla
- Stanford University, Stanford
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 8, 2024 · NCT04282044From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.